Chemours

NYSE: CC · Real-Time Price · USD
14.94
-0.09 (-0.60%)
At close: Aug 20, 2025, 9:45 AM

Chemours Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
502M 464M 713M 596M 619M 746M 1.81B 852M 738M 816M 1.1B 1.17B 1.25B 1.15B 1.45B 1.03B 1.14B 1.01B
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
228M 164M 152M 190M 169M 165M 158M 192M 189M 185M 175M 186M 177M 170M 169M 190M 178M 169M
Other Long-Term Assets
473M 519M 556M 384M 327M 349M 374M 535M 322M 647M 573M 460M 331M 349M 376M 361M 269M 286M
Receivables
959M 858M 770M 951M 896M 792M 610M 846M 890M 837M 626M 980M 1.07B 1.01B 720M 831M 802M 723M
Inventory
1.56B 1.55B 1.47B 1.44B 1.37B 1.39B 1.35B 1.31B 1.45B 1.49B 1.4B 1.32B 1.22B 1.17B 1.1B 1.02B 1.05B 988M
Other Current Assets
81M 61M 71M 95M 69M 668M 670M 595M 236M 63M 82M 75M 73M 68M 75M 493M 60M 67M
Total Current Assets
3.1B 2.93B 3.03B 3.08B 2.94B 3.6B 3.83B 3.68B 3.37B 3.2B 3.21B 3.54B 3.61B 3.39B 3.35B 3.37B 3.05B 2.79B
Property-Plant & Equipment
3.4B 3.42B 3.44B 3.43B 3.41B 3.46B 3.48B 3.38B 3.43B 3.42B 3.41B 3.3B 3.33B 3.36B 3.38B 3.34B 3.68B 3.66B
Goodwill & Intangibles
48M 48M 49M 49M 105M 105M 105M 107M 110M 112M 115M 117M 115M 107M 108M 110M 162M 163M
Total Long-Term Assets
4.39B 4.46B 4.49B 4.38B 4.31B 4.38B 4.42B 4.26B 4.29B 4.42B 4.43B 4.2B 4.12B 4.13B 4.21B 4.16B 4.43B 4.38B
Total Assets
7.49B 7.39B 7.51B 7.46B 7.25B 7.98B 8.25B 7.95B 7.66B 7.62B 7.64B 7.75B 7.73B 7.52B 7.55B 7.53B 7.48B 7.17B
Account Payables
995M 978M 1.12B 1.04B 911M 939M 1.13B 901M 1.01B 1.17B 1.23B 1.27B 1.25B 1.17B 1.16B 1.08B 1.06B 976M
Deferred Revenue
7M n/a n/a n/a 16M -29M 28M 5M 6M 6M 61M 53M 54M 7M 3M 2M 3M 5M
Short-Term Debt
38M 43M 54M 53M 37M 41M 51M 23M 25M 25M 25M 24M 24M 24M 25M 25M 25M 23M
Other Current Liabilities
708M 232M 554M 525M 130M 737M 759M 673M 665M 46M 88M 64M 59M 74M 391M 401M 353M 293M
Total Current Liabilities
1.85B 1.67B 1.8B 1.78B 1.56B 2.23B 2.49B 2.19B 2.19B 1.75B 1.89B 1.95B 1.89B 1.77B 1.86B 1.78B 1.67B 1.5B
Long-Term Debt
206M 4.06B 4.02B 3.99B 3.95B 3.97B 3.94B 3.94B 3.6B 3.6B 3.59B 3.51B 3.66B 3.69B 3.72B 3.83B 3.96B 3.97B
Other Long-Term Liabilities
5.17B 836M 824M 802M 780M 72M 835M 791M 802M 797M 793M 754M 741M 584M 656M 685M 608M 605M
Total Long-Term Liabilities
5.4B 5.14B 5.11B 5.03B 4.97B 4.99B 5.03B 5B 4.66B 4.65B 4.64B 4.51B 4.63B 4.58B 4.61B 4.75B 4.91B 4.82B
Total Liabilities
7.25B 6.81B 6.91B 6.8B 6.52B 7.22B 7.51B 7.19B 6.85B 6.4B 6.53B 6.46B 6.51B 6.36B 6.47B 6.53B 6.58B 6.32B
Total Debt
244M 4.38B 4.36B 4.29B 4.24B 4.26B 4.3B 4.17B 3.83B 3.82B 3.81B 3.73B 3.86B 3.95B 3.93B 4.03B 4.23B 4.18B
Common Stock
2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
Retained Earnings
1.26B 1.66B 1.72B 1.76B 1.83B 1.8B 1.78B 1.84B 1.86B 2.28B 2.17B 2.3B 2.1B 1.94B 1.75B 1.55B 1.38B 1.36B
Comprehensive Income
-293M -338M -367M -353M -347M -274M -274M -315M -282M -306M -343M -433M -378M -339M -364M -332M -318M -344M
Shareholders Equity
237M 579M 604M 657M 723M 752M 737M 755M 808M 1.23B 1.11B 1.28B 1.21B 1.17B 1.08B 998M 898M 850M
Total Investments
228M 164M 152M 190M 169M 165M 158M 192M 189M 185M 175M 186M 177M 170M 169M 190M 178M 169M